The global proteomics market was valued at nearly $5.1 billion in 2014 and is growing at a compound annual growth rate (CAGR) of 18.0% to reach a forecast value of $11.6 billion by 2019.
This report provides:
An overview of the global proteomics market, which covers: technologies, database and software markets, equipment markets, application markets and service markets.
Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.
Discussion of trends and opportunities, top-selling products, key players, and a competitive outlook.
Comprehensive company profiles across subsegments, such as protein chip providers, reagent providers, service providers, informatics and database providers, etc.
SCOPE AND FORMAT
The study scope covers MS instruments, consumables, workflow products, planar arrays, bead arrays and LOAC. It also covers the research, drug discovery and development, diagnostics and applied end-user market segments. The main geographical markets—North America, Europe, Asia and Rest of World (ROW)—are included.
The MS market is covered by instrument type, MS consumables, product type and end-user markets. The biochip market is covered by biochip type and the end-user market for each type. The diagnostics market is covered in some detail, including by major platform (i.e., MS, biochips), by disease type and for cancer by indication. This report provides the current market sizes for these segments, as well as their forecasted growth through 2019.
Technology status and market driving forces are discussed and analyzed. Factors that influence each market are also highlighted, including growth-driving forces, industry alliances and acquisitions, applications in diagnostics and drug discovery, customer needs and competitive trends.
Key industry acquisitions and strategic alliances are given for the three-year period from 2012 through 2014.
This report also examines the main patent trends within the industry and profiles 108 proteomics companies.